Phreesia, Inc. (PHR) Q3 2026 Earnings Call Transcript
Phreesia, Inc. (PHR) Q3 2026 Earnings Call Transcript
Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Stay Ahead of the Game With Phreesia (PHR) Q3 Earnings: Wall Street's Insights on Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Phreesia (PHR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2025.
Phreesia (PHR) Earnings Expected to Grow: Should You Buy?
Phreesia (PHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
After Plunging 18.2% in 4 Weeks, Here's Why the Trend Might Reverse for Phreesia (PHR)
The heavy selling pressure might have exhausted for Phreesia (PHR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Holding Phreesia Despite Initial Post-Earnings Disappointment
Phreesia's stock fell post-earnings for the first time since June 2024 amid apparent disappointment with the company's largest-ever acquisition. Yet improving cash flow margin and net income trends continue to make the stock a buy. This non-cyclical growth story still has plenty of runway as the company works to expand into its large TAM opportunities.
Phreesia, Inc. (PHR) Q2 2026 Earnings Call Transcript
Phreesia, Inc. (NYSE:PHR ) Q2 2026 Earnings Call September 4, 2025 5:00 PM EDT Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Co-Founder, CEO & Director Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Jailendra Singh - Truist Securities, Inc., Research Division Jeffrey Garro - Stephens Inc., Research Division Richard Close - Canaccord Genuity Corp., Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division Jessica Tassan - Piper Sandler & Co., Research Division Ryan MacDonald - Needham & Company, LLC, Research Division Daniel Grosslight - Citigroup Inc., Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Brian Tanquilut - Jefferies LLC, Research Division Gene Mannheimer Presentation Operator Good morning, ladies and gentlemen, and welcome to the Phreesia's Second Quarter Fiscal 2026 Earnings Call.
Why Phreesia Feels Like The Right Bet In Healthcare Tech
Phreesia is on track to meet FY26 revenue targets, driven by steady client growth and strong average revenue per client. Margins are improving, with adjusted EBITDA trending toward high teens and free cash flow beginning to emerge, supporting long-term leverage. Valuation is balanced at 3.3x forward EV/S, but real upside depends on sustained margin expansion and cash flow conversion.
All You Need to Know About Phreesia (PHR) Rating Upgrade to Buy
Phreesia (PHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Phreesia (PHR) Upgraded to Buy: What Does It Mean for the Stock?
Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Phreesia: Monetization Playbook To Help Drive Revenue Acceleration
Phreesia delivered a solid 1Q26 with strong profitability and steady client growth, despite a slight deceleration in revenue growth versus last year. Monetization per client is improving, supported by successful product launches and a strategic focus on larger, higher-value customers. The new 2.5 million share buyback program signals management's confidence in the business and provides additional support for the stock.
Phreesia, Inc. (PHR) Q1 2026 Earnings Call Transcript
Phreesia, Inc. (NYSE:PHR ) Q1 2026 Earnings Conference Call May 28, 2025 8:30 AM ET Company Participants Balaji Gandhi - CFO Chaim Indig - CEO Conference Call Participants Anne Samuel - JPMorgan Jailendra Singh - Truist Securities Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity John Ransom - Raymond James Daniel Grosslight - Citi William Jellison - D.A. Davidson Ryan MacDonald - Needham & Company Jeff Garro - Stephens Scott Schoenhaus - Keybank Jared Hass - William Blair Aaron Kempson - Citizens JMP Gene Mannheimer - Freedom Capital Markets Joe Vruwink - Baird Operator Good morning, ladies and gentlemen.
